Early Onset Csf1r Related Disorder Cn381263
A severe neurodegenerative condition affecting brain development and immune function. Presents early in life with progressive neurological decline. Treatment is supportive, focusing on symptom management.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Vision loss
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Developmental regression
(neurologic)Spasticity
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Early Intensive Rehabilitation Program
Structured physical therapy program focusing on motor skill development, strength building, and functional mobility exercises tailored to the child's developmental stage and specific motor impairments.
Symptomatic Seizure Management
Anticonvulsant medications prescribed based on seizure type and frequency when epileptiform activity is present. Treatment decisions should be guided by EEG findings and neurologist expertise.
Additional treatment options
Neurodevelopmental Support Services
Comprehensive psychological and developmental support including cognitive assessments, behavioral interventions, and educational planning to address learning difficulties and behavioral challenges associated with the disorder.
psychologicalMultidisciplinary Surveillance Program
Regular comprehensive assessments by specialists in neurology, developmental pediatrics, genetics, and other relevant fields to monitor disease progression and adjust management strategies accordingly.
monitoringOccupational Therapy Services
Targeted occupational therapy to develop fine motor skills, self-care abilities, and adaptive strategies for daily living activities. Focuses on maximizing independence in feeding, dressing, and play activities.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Early Onset Csf1r Related Disorder Cn381263?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Early Onset Csf1r Related Disorder Cn381263. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy